Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 13Oropharyngeal Neoplasms 11Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Mouth Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Urinary Bladder Neoplasms 6Nasopharyngeal Carcinoma 6Hypopharyngeal Neoplasms 6Pancreatic Neoplasms 5Mesothelioma, Malignant 5Uterine Cervical Neoplasms 4Ovarian Neoplasms 4Medulloblastoma 4Ganglioneuroblastoma 4Gallbladder Neoplasms 4Neuroblastoma 3Lymphoid Interstitial Pneumonia 3Cholangiocarcinoma 3Triple Negative Breast Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1

Interventions

apatinib 2Hyperthermic Intraperitoneal Chemotherapy 2Gastrectomy 2trastuzumab deruxtecan 1taxane 1sintilimab 1pembrolizumab 1durvalumab 1disitamab vedotin 1cabozantinib 1Taxes 1Tadalafil 1SHR-1701 1S 1 (combination) 1Platinum 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Indocyanine Green 1Immunotherapy, Adoptive 1Cytoreduction Surgical Procedures 1Cisplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastric Adenocarcinoma × 1,2-diaminocyclohexaneplatinum II citrate × 1 year × Clear all
NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡